The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Semaphorins and plexins as therapeutic targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression
Zhou, H., Binmadi, N. O., Yang, Y.-H., Proia, P., & Basile, J. R. (2012) · Angiogenesis · doi:10.1007/s10456-012-9268-y · Cited by 75
RetractedTamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G.-L., Song, H.-J., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M.-M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80063-x · Cited by 1,157
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Van Ginderachter, J. A., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 629
Osteoprotection by semaphorin 3A
Hayashi, M., Nakashima, T., Taniguchi, M., Kodama, T., Kumanogoh, A., & Takayanagi, H. (2012) · Nature · doi:10.1038/nature11000 · Cited by 606
Semaphorin III is needed for normal patterning and growth of nerves, bones and heart
Behar, O., Golden, J. A., Mashimo, H., Schoen, F. J., & Fishman, M. C. (1996) · Nature · doi:10.1038/383525a0 · Cited by 583
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function
Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., et al. (2003) · Nature · doi:10.1038/nature01784 · Cited by 576
Semaphorin 3E and Plexin-D1 Control Vascular Pattern Independently of Neuropilins
Gu, C., Yoshida, Y., Livet, J., Reimert, D. V., Mann, F., Merte, J., Henderson, C. E., Jessell, T. M., Kolodkin, A. L., & Ginty, D. D. (2005) · Science · doi:10.1126/science.1105416 · Cited by 543
An overview of the regulation of bone remodelling at the cellular level
Kular, J., Tickner, J., Chim, S. M., & Xu, J. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.021 · Cited by 534
Disruption of Semaphorin III/D Gene Causes Severe Abnormality in Peripheral Nerve Projection
Taniguchi, M., Yuasa, S., Fujisawa, H., Naruse, I., Saga, S., Mishina, M., & Yagi, T. (1997) · Neuron · doi:10.1016/s0896-6273(00)80368-2 · Cited by 516
Semaphorin 7A promotes axon outgrowth through integrins and MAPKs
Jeroen Pasterkamp, R., Peschon, J. J., Spriggs, M. K., & Kolodkin, A. L. (2003) · Nature · doi:10.1038/nature01790 · Cited by 515
Cited by
Barcoded viral tracing of single-cell interactions in central nervous system inflammation
Clark, I. C., Gutiérrez-Vázquez, C., Wheeler, M. A., Li, Z., Rothhammer, V., Linnerbauer, M., Sanmarco, L. M., Guo, L., Blain, M., Zandee, S. E. J., et al. (2021) · Science · doi:10.1126/science.abf1230 · Cited by 285
Zhou, X., Wahane, S., Friedl, M.-S., Kluge, M., Friedel, C. C., Avrampou, K., Zachariou, V., Guo, L., Zhang, B., He, X., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0597-7 · Cited by 275
Origin and evolution of plexins, semaphorins, and Met receptor tyrosine kinases
Junqueira Alves, C., Yotoko, K., Zou, H., & Friedel, R. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-38512-y · Cited by 72
A genome-wide association study for extremely high intelligence
Zabaneh, D., Krapohl, E., Gaspar, H. A., Curtis, C., Lee, S. H., Patel, H., Newhouse, S., Wu, H. M., Simpson, M. A., Putallaz, M., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.121 · Cited by 71
Guryanova, O. A., Lieu, Y. K., Garrett-Bakelman, F. E., Spitzer, B., Glass, J. L., Shank, K., Martinez, A. B. V., Rivera, S. A., Durham, B. H., Rapaport, F., et al. (2016) · Leukemia · doi:10.1038/leu.2015.358 · Cited by 66
Metadata
- Authors
- Worzfeld, T., & Offermanns, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-08
- Volume
- 13
- Issue
- 8
- Pages
- 603-621
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2071066049
- Cited by
- 318
- References
- 194
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Semaphorins and plexins as therapeutic targets. https://app.cochat.ai/papers/10.1038/nrd4337
- The paper
- Worzfeld, T., & Offermanns, S. (2014). Semaphorins and plexins as therapeutic targets. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd4337
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
